When it comes to ureteral stents, urine calcium (Ca) and magnesium (Mg) salt deposits can contribute to stent complications such as encrustation.1,2 The cause and rate of encrustation is multifactorial and can include factors such as body chemistry and medical condition of the patient, stent indwell time, and surface material properties of the stent.2-4 The Tria stent is the only commercially available stent that may help control the accumulation of Ca and Mg salts.5,6
DISCOVER WHY TRIA IS THE URETERAL STENT BEING CONSIDERED IN OPERATING ROOMS.
PercuShield™ TechnologyDesigned to provide protection against salt accumulation.5,6 This technology is also embedded on the inner and outer surfaces of the stent to provide protection throughout the entire in dwell. |
 |
 |
Longer Indwell TimesTria features biocompatible material designed to enable indwell time up to 365 days,5,7 which is especially important in times with limited OR access due to the COVID-19 pandemic. |
Stiffer During PlacementThe Tria Stent is designed to be stiffer during placement to navigate patient anatomy while softening by over 40% at body temperature,5,8 which may promote greater patient tolerability.9 |
 |
 |
Varying SizesAvailable in soft and firm stent durometers and in an expansive range of diameters and lengths to cover a variety of patient types. |
